FDA Inspection
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCWyeth BioPharma Division of Wyeth Pharmaceuticals LLC – FDA Inspection, Apr 28, 2017
Record Details
This FDA Inspection record concerns Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC, with an inspection on April 28, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 28, 2017
- Product Type
- Biologics
View Company Profile
ID · f122bb42-1ac1-4ff2-a255-0f95cfbe9412
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1020234
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
16| Date | Classification | Office | Project area |
|---|---|---|---|
| August 6, 2026 | Not classified | New England District Office | |
| April 8, 2026 | Not classified | New England District Office | |
| February 11, 2026 | NAI | Human Cellular, Tissue, and Gene Therapies | |
| October 13, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
- FDA Inspection 1331288 - 2026-08-06
- FDA Inspection 1311392 - 2026-04-08
- FDA Inspection 1304580 - 2026-02-11
- FDA Inspection 1223617 - 2023-10-13
- FDA Inspection 1218069 - 2023-09-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.